Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 79Multiple Myeloma 73Prostatic Neoplasms 66Neoplasms 50Lymphoma 45Leukemia, Myeloid, Acute 44Neoplasm Metastasis 39Melanoma 39Lymphoma, Non-Hodgkin 34Ovarian Neoplasms 33Lung Neoplasms 32Squamous Cell Carcinoma of Head and Neck 31Hematologic Neoplasms 29Leukemia, Lymphocytic, Chronic, B-Cell 28Colorectal Neoplasms 27Hodgkin Disease 24Triple Negative Breast Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Sarcoma 20Fallopian Tube Neoplasms 20Pancreatic Neoplasms 19Carcinoma, Renal Cell 19Lymphoma, Mantle-Cell 18Lymphoma, Follicular 18Glioma 18Recurrence 17Leukemia 17Head and Neck Neoplasms 17

Interventions

Haloperidol 1Chlorpromazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Delirium × 90 days × Clear all
NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡